Brimstalt Therapeutics
Pre-clinicalBrimstalt is developing novel therapies for cancer offering improved safety and efficacy profiles for better patient outcomes
Founded
2021
Focus
Small Molecules
About
Brimstalt is developing novel therapies for cancer offering improved safety and efficacy profiles for better patient outcomes
Funding History
1Total raised: $8M
Seed$8MUndisclosedMay 15, 2022
Company Info
TypePrivate
Founded2021
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile